Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Bullish +65

Why Is Axon Enterprise Stock Surging On Tuesday? - Benzinga

AI-generated analysis

πŸ“ˆ Axon Enterprise stock surged on Tuesday after disclosures showed President Trump purchased $1M-$5M of shares on Feb. 10.

πŸš” ICE introduced a $220 million procurement plan on Feb. 24 seeking ~17,800 new Tasers and unlimited cartridges.

πŸ“Š Axon produces nearly 90% of all U.S. Tasers, aligning its product profile with the federal agency's specifications.

βš–οΈ No contract has been awarded yet, and CNBC reports no evidence Trump was involved in or aware of the procurement process.

🏦 Trump's investments are held in an independently managed trust, leaving him with no role in active trading decisions.

πŸ“‰ Stock is trading 14.1% above its 20-day SMA but remains 2.6% below its 200-day SMA at $536.07.

πŸ›‘ Key resistance level identified at $588.50 where rallies may stall after a strong run off the April low.

πŸ›‘οΈ Key support level identified at $484.50, acting as a floor if momentum cools during premarket trading.

πŸ“… The stock was up 2.02% to $520.91 in premarket trading on Tuesday according to Benzinga Pro data.

πŸ” A death cross formed in November 2025, with the 50-day SMA remaining below the 200-day SMA.

Bullish Signals
  • President Trump's significant $1M-$5M stock purchase signals strong confidence in Axon's long-term prospects.
  • ICE's $220 million procurement plan for ~17,800 Tasers represents a massive potential contract opportunity.
  • Axon holds a dominant market position, producing nearly 90% of all U.S. Tasers.
  • Product specifications in the federal notice align exclusively with Axon's core product profile.
  • Stock is trading 14.1% above its 20-day moving average, indicating a strong near-term bullish trend.
Risk Factors
  • No contract has been awarded yet, meaning the potential revenue from ICE remains uncertain and unconfirmed.
  • The stock is still trading below its 200-day moving average, suggesting it has not fully reclaimed the longer-term institutional trend line.
  • A 'death cross' exists with the 50-day SMA below the 200-day SMA, which often produces choppy trades and supply from long-term holders.
Full Analysis
Axon Enterprise Inc. (NASDAQ: AXON) shares surged on Tuesday following federal financial disclosures revealing that President Donald Trump purchased between $1 million and $5 million of the company's stock on February 10. This significant investment occurred shortly before U.S. Immigration and Customs Enforcement (ICE) announced a $220 million procurement plan to acquire approximately 17,800 new Tasers, cartridges, and training materials. While the federal procurement notice did not explicitly name a manufacturer, industry data indicates Axon produces nearly 90% of all U.S. Tasers, and specifications align closely with its core product profile. Although no contract has been awarded and there is no evidence Trump was involved in the specific process, the timing of his purchase coincides with ICE's massive order request. Technically, AXON stock traded at $520.91 during premarket trading, sitting 14.1% above its 20-day moving average but still below its 200-day moving average. Analysts note that while the near-term trend is bullish, the stock faces resistance near $588.50 and support around $484.50 as it navigates a mixed moving-average structure. The article clarifies that Trump's investments are held in an independently managed trust, meaning he has no active role in trading decisions. It also notes historical precedents where Trump acquired stakes in companies like Dell and NVIDIA before related policy actions were taken.